Dr. Clayton Yates - 15 Apr 2026 Form 4 Insider Report for Genvor Inc (GNVR)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: GNVR
Reported as of: 15 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Nov 2026, 12:53:01 UTC
Prior SEC filing: 23 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Dr. Clayton Yates

Filing notes and source

Key filing fact

Dr. Clayton Yates filed Form 4 for Genvor Inc (GNVR) on 03 Nov 2026.

Key facts

This page summarizes Dr. Clayton Yates's Form 4 filing for Genvor Inc (GNVR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Nov 2026, 12:53.

Change

Previous filing in this sequence was filed on 23 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002000242 Primary reporting owner

Yates Clayton Clopton

Relationship: Director, 10%+ Owner
Address: 1550 W HORIZON RIDGE PKWY, STE R #3040, HENDERSON
Signature: /s/ Dr. Clayton Yates
Signature date: 03 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GNVR transaction

Common Stock

Award

Transaction value
Shares: +200,000
Change %: +50%
Price: $0.5000^*
Shares after: 600,000
Date: 15 Apr 2026
Ownership: ACT Holdings, LLC
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares issued upon Dr. Yates' conversion of $100,000 in outstanding payables owed by the Company to Dr. Yates, pursuant to his scientific advisor agreement with the Company and the Company's restructured compensation package previously approved by the Company, which permits Dr. Yates to convert amounts due to him into Company common stock.

Footnote F2

Dr. Yates has voting and dispositive power with respect to shares held in the name of ACT Holdings, LLC, and is therefore deemed to be beneficial owner of shares held in its name.